News & Events

Asceneuron presents the novel M1-targeting compound ASN-51

- Event
Asceneuron presents the novel M1-targeting compound ASN-51 at the 11th International Conference on Alzheimer's and Parkinson's disease held 6-10 March 2013 in Florence, Italy.

Asceneuron presents the novel M1-targeting compound ASN-51 at the 11th International Conference on Alzheimer's and Parkinson's disease held 6-10 March 2013 in Florence, Italy.

Read the comments in the Alzheimer Reseach Forum News of March 26th, 2013: click here